Ligand Pharmaceuticals
LGND
#3607
Rank
C$5.28 B
Marketcap
C$268.52
Share price
-1.59%
Change (1 day)
67.92%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): C$88.66 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.25 Billion. In 2024 the company made an earning of C$7.72 Million a decrease over its 2023 earnings that were of C$89.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$88.66 M1047.92%
2024 C$7.72 M-91.37%
2023 C$89.49 M-7.59%
2022 C$96.84 M4%
2021 C$93.12 M296.42%
2020 C$23.49 M-97.97%
2019 C$1.15 B275.62%
2018 C$0.30 B237.48%
2017 C$91.37 M49.05%
2016 C$61.3 M55.41%
2015 C$39.44 M36.87%
2014 C$28.81 M29.59%
2013 C$22.23 M1309.35%
2012 C$1.57 M-43.97%
2011 C$2.81 M-113.19%
2010 -C$21.36 Million59.86%
2009 -C$13.36 Million-61.33%
2008 -C$34.55 Million-58.75%
2007 -C$83.74 Million20.52%
2006 -C$69.48 Million81.27%
2005 -C$38.33 Million
2003 -C$26.69 Million-20.6%
2002 -C$33.61 Million4.38%
2001 -C$32.2 Million-48.83%
2000 -C$62.92 Million-19.74%
1999 -C$78.4 Million-19.06%
1998 -C$96.85 Million126.71%
1997 -C$42.72 Million-5.83%
1996 -C$45.37 Million136.23%
1995 -C$19.21 Million-33.97%
1994 -C$29.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.47 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$86.11 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.97 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$32.12 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.49 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.31 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.17 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.38 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$45.07 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA